Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | The outcome of COVID-19 in Parkinson’s patients

Alfonso Fasano, MD, PhD, University of Toronto, Toronto, Canada, discusses the outcomes of COVID-19 infection in patients with Parkinson’s disease. Inherently, movement disorders do not affect the outcome of COVID-19 infection, however, older patients or those with comorbidities could be at higher risk. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).